共查询到20条相似文献，搜索用时 156 毫秒
1.
2.
马波沙星的致突变性和致畸性研究 总被引：3，自引：0，他引：3
选用Wistar大鼠和昆明系小鼠对马波沙星的遗传毒性进行研究。试验结果显示，马波沙星在抑菌剂量之下对鼠伤寒沙门氏菌不产生致突变作用；马波沙星不引起小鼠骨髓有微核多染红细胞率增加；马波沙星不引起雄性小鼠生殖细胞染色体畸变而造成的早期胚胎死亡；20mg／kg b．w．和100mg／kg b．w．剂量马波沙星对母鼠的生殖机能和胎鼠的生长发育无明显影响，对胎鼠不产生致畸作用，500mg／kg b．w．剂量马波沙星对胎鼠体长和骨骼发育有一定影响，但不存在剂量反应关系。上述结果表明，马波沙星无明显的致突变性和致畸性。 相似文献
3.
考察了第三代喹诺酮类抗菌药马波沙星在高温、高湿、光照以及加速试验和长期试验中的稳定性进行了测定,为马波沙星再生产、包装、贮存、运输条件提供了有力的科学依据,并通过长期试验确定了马波沙星的有效期。 相似文献
4.
合成、鉴定了马波沙星(MBF)人工抗原,为马波沙星单克隆抗体的制备及其免疫学检测方法的建立奠定基础。以牛血清白蛋白(BSA)、鸡卵清蛋白(OVA)为载体蛋白,采用碳二亚胺法分别合成马波沙星免疫抗原(MBF-BSA)和包被抗原(MBF-OVA),并使用紫外分光光度法、SDS-PAGE、ELISA方法鉴定人工抗原合成效果。初步鉴定结果显示,MBF-BSA与MBF-OVA均偶联成功;用免疫抗原MBF-BSA免疫小鼠,经ELISA方法检测,五免后血清中抗体效价可达1∶5.12×105,半数抑制率为90.20 ng/m L。研究表明,马波沙星人工抗原合成成功,其免疫抗原具有良好的免疫原性,免疫小鼠可获得高效价、高特异性多克隆抗体。 相似文献
5.
马波沙星是一种新型的氟喹诺酮类抗菌剂,对革兰阴性菌、革兰阳性菌和支原体均有抑制或杀灭作用。通过体外抑菌试验和生物试验探究马波沙星对家蚕主要细菌病害的防治效果。马波沙星对苏芸金芽孢杆菌(Bacillus thuringiensis)、黑胸败血芽孢杆菌(Bacillus bombysepticus)、沙雷铁氏菌(俗称灵菌,Serratia marcescens)的体外最低抑菌浓度(MIC)分别为0.25 mg/L、0.50 mg/L、0.25 mg/L,最低杀菌浓度(MBC)分别为8 mg/L、16 mg/L、32 mg/L,均大于或等于盐酸环丙沙星的MIC和MBC值。以质量浓度为50 mg/L、200 mg/L的马波沙星药液给5龄起蚕添食8 h,对由苏芸金芽孢杆菌、黑胸败血芽孢杆菌感染引起的家蚕败血病的防治效率为100%;以800 mg/L马波沙星药液给5龄起蚕添食24 h或连续3 d每日给药8 h,对由灵菌感染引起的家蚕败血病的防治效率为100%,防治效果显著优于盐酸环丙沙星(P0.05)。5龄起蚕接种苏芸金芽孢杆菌3 h后添食50 mg/L马波沙星药液24 h,对家蚕败血病的防治效率为100%;5龄起蚕接种黑胸败血芽孢杆菌1 h后添食100 mg/L马波沙星药液24 h和接种3 h后添食200 mg/L马波沙星药液24 h,对家蚕败血病的防治效率均可达90.0%以上;5龄起蚕接种灵菌3 h后添食1 600 mg/L马波沙星药液24 h,对家蚕败血病的防治效率可达90.0%以上,防治效果显著优于盐酸环丙沙星(P0.05)。药物对家蚕的毒性试验表明,给3龄、4龄、5龄家蚕幼虫连续添食200 mg/L、600 mg/L、1 000 mg/L的马波沙星药液,对家蚕的生长发育和茧质无不良影响。试验结果初步显示,马波沙星对家蚕无安全风险,可以用于家蚕细菌性败血病的防治。 相似文献
6.
7.
8.
建立并验证了高效液相色谱法测定马波沙星片中马波沙星氧化物含量的方法。试验采用十八烷基硅烷键合硅胶色谱柱(4.6 mm×250 mm,5μm),以辛烷磺酸钠磷酸盐缓冲液-甲醇-四氢呋喃(65∶32∶3)为流动相,流速1.0 m L/min,柱温30℃,检测波长为210～400 nm。试验结果表明:马波沙星氧化物在0.5～100μg/m L范国内线性良好,R^2=0.9997,平均回收率为95.9%(n=9),RSD≤1.5%。方法检测限为0.2μg/m L,专属性好,可用于马波沙星片的质量控制。 相似文献
9.
考察马波沙星对猪临床分离病原菌的体外抑菌活性,以期为临床应用提供依据。采用琼脂二倍稀释法测定马波沙星对猪临床分离大肠杆菌、金黄色葡萄球菌和链球菌的最小抑菌浓度(MIC),并以土霉素、恩诺沙星、诺氟沙星、环丙沙星、庆大霉素和多西环素作为对照药物。结果表明:马波沙星对猪临床分离病原菌大肠杆菌、金黄色葡萄球菌和链球菌均有较低的最小抑菌浓度,对临床分离大肠杆菌、金黄色葡萄球菌和链球菌的抑菌活性明显高于诺氟沙星、环丙沙星、庆大霉素和强力霉素,对临床分离大肠杆菌的抑菌活性高于恩诺沙星。马波沙星对引起猪乳房炎-子宫炎-无乳综合征(MMA)的主要病原菌的抑菌活性优于常用抗菌药。 相似文献
10.
11.
12.
13.
14.
优质乳是奶业发展的方向 总被引：1，自引：1，他引：0
发展方向决定兴衰存亡。我国奶业经历了30年的快速发展,取得了巨大成就,但是也正在面临发展新方向的抉择。这个新方向就是发展优质乳,需要明确提出"一杯优质牛奶振兴一个民族"的理念。我国有关奶业科研团队,经过近20年的艰苦探索和协同创新,已经形成了适合国情的"优质乳生产的奶牛营养调控与规范化饲养技术"成果并示范应用,示范结果表明,在奶牛生产中使蛋白质饲料利用效率提高8%~15%,乳脂率和乳蛋白率分别达到3.5%和3.1%,牛奶体细胞数低于40万个,细菌总数低于10万CFU/mL,完全达到国际上优质乳的营养品质和卫生安全水平。如何从国家政策的战略设计上进一步明确优质乳的发展方向,积极组织推广优质乳科技成果,大力发展和弘扬优质、健康、向上的奶业文化,应该引起重视。 相似文献
15.
16.
Nutraceuticals are increasingly applied to the management of equine arthritis and joint disease, particularly those based upon glucosamine and chondroitin sulphate. While the first report of using glucosamine in horses appeared more than 25 years ago, it was not until 1992 that isolated studies began to be reported. Since that time, 15 in vivo papers have been published in the equine literature, usually on products already commercially available and often seeking evidence for efficacy. These studies demonstrate an encouraging trend to manufacturers of these products investing in research, but most do not meet a quality standard that provides sufficient confidence in the results reported. This review discusses the entirety of published in vivo research on glucosamine‐based nutraceuticals (GBN) for horses, including that on Cosequin, Cortaflex, Synequin, Sasha's EQ, Myristol, chondroitin sulphate, glucosamine sulphate and glucosamine hydrochloride; and considers experimental limitations of this research along with their impact on interpretation of results. A quality score was calculated for each paper according to preset quality criteria. A minimum quality standard of 60% was set as the threshold for confidence in interpretation of results. Of the 15 papers reviewed, only 3 met the minimum quality standard. Experimental limitations of each research paper are discussed. It is concluded that the quality of studies in this area is generally low, prohibiting meaningful interpretation of the reported results. New high quality research on GBN for horses is needed and recommendations for future research are discussed. 相似文献
17.
Federico Sacchini Kathleen P Freeman 《Journal of veterinary diagnostic investigation》2008,20(3):266-273
An increasing number of veterinary laboratories worldwide have obtained or are seeking certification based on international standards, such as the International Organization for Standardization/International Electrotechnical Commission 17025. Compliance with any certification standard or quality management system requires quality documentation, an activity that may present several unique challenges in the case of veterinary laboratories. Research specifically addressing quality documentation is conspicuously absent in the veterinary literature. This article provides an overview of the quality system documentation needed to comply with a quality management system with an emphasis on preparing written standard operating procedures specific for veterinary laboratories. In addition, the quality documentation challenges that are unique to veterinary clinical pathology laboratories are critically evaluated against the existing quality standards and discussed with respect to possible solutions and/or recommended courses of action. Documentation challenges include the establishment of quality requirements for veterinary tests, the use or modification of human analytic methods for animal samples, the limited availability of quality control materials satisfactory for veterinary clinical pathology laboratories, the limited availability of veterinary proficiency programs, and the complications in establishing species-specific reference intervals. 相似文献
18.
19.
Bente Flatland Kathleen P. Freeman Linda M. Vap Kendal E. Harr 《Veterinary clinical pathology / American Society for Veterinary Clinical Pathology》2013,42(4):405-423
Point‐of‐care testing (POCT) refers to any laboratory testing performed outside the conventional reference laboratory and implies close proximity to patients. Instrumental POCT systems consist of small, handheld or benchtop analyzers. These have potential utility in many veterinary settings, including private clinics, academic veterinary medical centers, the community (eg, remote area veterinary medical teams), and for research applications in academia, government, and industry. Concern about the quality of veterinary in‐clinic testing has been expressed in published veterinary literature; however, little guidance focusing on POCT is available. Recognizing this void, the ASVCP formed a subcommittee in 2009 charged with developing quality assurance (QA) guidelines for veterinary POCT. Guidelines were developed through literature review and a consensus process. Major recommendations include (1) taking a formalized approach to POCT within the facility, (2) use of written policies, standard operating procedures, forms, and logs, (3) operator training, including periodic assessment of skills, (4) assessment of instrument analytical performance and use of both statistical quality control and external quality assessment programs, (5) use of properly established or validated reference intervals, (6) and ensuring accurate patient results reporting. Where possible, given instrument analytical performance, use of a validated 13s control rule for interpretation of control data is recommended. These guidelines are aimed at veterinarians and veterinary technicians seeking to improve management of POCT in their clinical or research setting, and address QA of small chemistry and hematology instruments. These guidelines are not intended to be all‐inclusive; rather, they provide a minimum standard for maintenance of POCT instruments in the veterinary setting. 相似文献
20.
为寻找安全有效防治犬真菌性皮肤病的临床药物,采用乳化法制备出防治犬真菌性皮肤病的复方中药软膏剂,并通过对中药软膏的外观性状、稳定性、刺激性、局部致敏性等质量标准进行综合评价。试验结果表明,本试验制备的中药软膏剂外观细腻,质地均匀,质量稳定,无明显急性毒性反应、无刺激性、不产生局部及全身过敏反应。 相似文献